Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Novak

Showing results (221-230 of 331) with videos related to

Pageof 34
Sort By:
Studies in Health Technology and Informatics|July 9, 2015
3D Texture Analysis of Heterogeneous MRI Data for Diagnostic Classification of Childhood Brain TumoursAhmed E Fetit, Jan Novak, Daniel Rodriguez, et al.
Journal of the American Society of Nephrology : JASN|February 24, 2004
Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathyIvan C Moura, Michelle Arcos-Fajardo, Charlotte Sadaka, et al.
Journal of Nephrology|September 7, 2019
Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?Hana Ciferska, Eva Honsova, Alena Lodererova, et al.
Multiple Sclerosis and Related Disorders|December 9, 2022
Experiences of health tracking in mobile apps for multiple sclerosis: A qualitative content analysis of user reviewsAshley Polhemus, Sara Simblett, Erin Dawe Lane, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2021
The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registryLukas Semerad, Zuzana Sustkova, Petr Cetkovsky, et al.
Analytical and Bioanalytical Chemistry|August 23, 2007
Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathyMatthew B Renfrow, C Logan Mackay, Michael J Chalmers, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 5, 2014
N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathyMilada Stuchlova Horynova, Alena Vrablikova, Tyler J Stewart, et al.
Journal of Virology|April 3, 2026
Dual role of glycosylation in resistance to CD4-binding site broadly neutralizing antibodiesTeresa Murphy, Meagan Kelly, Kai S Shimagaki, et al.
Molecular Immunology|February 6, 2007
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteinsJennifer S Moore, Rose Kulhavy, Milan Tomana, et al.
Journal of Virology|October 12, 2018
Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity ProfilesAudra A Hargett, Qing Wei, Barbora Knoppova, et al.
Pageof 34

Showing results (221-230 of 331) with videos related to

Sort By:
Pageof 34
Studies in Health Technology and Informatics|July 9, 2015
3D Texture Analysis of Heterogeneous MRI Data for Diagnostic Classification of Childhood Brain TumoursAhmed E Fetit, Jan Novak, Daniel Rodriguez, et al.
Journal of the American Society of Nephrology : JASN|February 24, 2004
Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathyIvan C Moura, Michelle Arcos-Fajardo, Charlotte Sadaka, et al.
Journal of Nephrology|September 7, 2019
Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?Hana Ciferska, Eva Honsova, Alena Lodererova, et al.
Multiple Sclerosis and Related Disorders|December 9, 2022
Experiences of health tracking in mobile apps for multiple sclerosis: A qualitative content analysis of user reviewsAshley Polhemus, Sara Simblett, Erin Dawe Lane, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2021
The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registryLukas Semerad, Zuzana Sustkova, Petr Cetkovsky, et al.
Analytical and Bioanalytical Chemistry|August 23, 2007
Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathyMatthew B Renfrow, C Logan Mackay, Michael J Chalmers, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 5, 2014
N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathyMilada Stuchlova Horynova, Alena Vrablikova, Tyler J Stewart, et al.
Journal of Virology|April 3, 2026
Dual role of glycosylation in resistance to CD4-binding site broadly neutralizing antibodiesTeresa Murphy, Meagan Kelly, Kai S Shimagaki, et al.
Molecular Immunology|February 6, 2007
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteinsJennifer S Moore, Rose Kulhavy, Milan Tomana, et al.
Journal of Virology|October 12, 2018
Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity ProfilesAudra A Hargett, Qing Wei, Barbora Knoppova, et al.
Pageof 34